# n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation

> **NCT01198275** · PHASE3 · COMPLETED · sponsor: **Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia** · enrollment: 199 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** n-3 PUFAs
- **DRUG:** Placebo
- **DRUG:** RASS inhibitors and/or RAS blockers
- **DRUG:** Amiodarone

## Key facts

- **NCT ID:** NCT01198275
- **Lead sponsor:** Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2012-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01198275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01198275, "n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01198275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*